Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Paclitaxel-Herceptin Adjuvant Therapy
NCT00003992Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 1999
- Primary completion
- Jan 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by National Cancer Institute. Started Aug 1999; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003992.